Expertise in
4
conditions

Antonia Digklia

Lausanne Branch, 
Lausanne, VD, CH 
Expertise in
4
conditions
Lausanne Branch, 
Lausanne, VD, CH 

Overview

Antonia Digklia practices practicing medicine in Lausanne, Switzerland.

Ms. Digklia is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Adult Soft Tissue Sarcoma, Clear Cell Sarcoma, Liposarcoma, Pancreaticoduodenectomy, and Tissue Biopsy.

She is actively involved in clinical research, co-authoring 83 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Lausanne Branch, Lausanne, VD, Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Irreversible Electroporation (IRE) Followed by Nivolumab in Patients With Metastatic Pancreatic Cancer: a Multicenter Single-arm Phase II Trial
Irreversible Electroporation (IRE) Followed by Nivolumab in Patients With Metastatic Pancreatic Cancer: a Multicenter Single-arm Phase II Trial
Enrollment Status: Terminated
Publish Date: July 18, 2023
Intervention Type: Drug
Study Drug: Nivolumab
Study Phase: Phase 2
NAPAGE: NAb-PAclitaxel and GEmcitabine in Advanced Soft Tissue Sarcoma. A Multicenter Open-label Single Arm Phase Ib/IIa Trial
NAPAGE: NAb-PAclitaxel and GEmcitabine in Advanced Soft Tissue Sarcoma. A Multicenter Open-label Single Arm Phase Ib/IIa Trial
Enrollment Status: Terminated
Publish Date: September 28, 2022
Intervention Type: Drug
Study Drugs: Nab-paclitaxel, Gemcitabine
Study Phase: Phase 1/Phase 2
View 1 Less Clinical Trial

83 Total Publications

Hepatopancreatobiliary surgery in 2026 : breakthroughs, challenges, and perspectives
Hepatopancreatobiliary surgery in 2026 : breakthroughs, challenges, and perspectives
Journal: Revue medicale suisse
Published: June 11, 2026

Frequently Asked Questions about Antonia Digklia

Is Antonia Digklia a top-rated expert for Adult Soft Tissue Sarcoma?

MediFind is an objective health platform that identifies experts based on real-world data. Antonia Digklia is classified as an Advanced expert for Adult Soft Tissue Sarcoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Antonia Digklia participate in research or clinical trials?

Yes. Antonia Digklia has published 83 articles and abstracts on conditions like Adult Soft Tissue Sarcoma. You can view a list of Antonia Digklia's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Digklia's expertise for a condition
ConditionClose
      View All 27 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile